Hematopoietic stem-cell therapy(Assistance Publique Hopitaux De Paris)

N/A

Report date: 2026/04/29 20:02:18

Base Information

Drug NameHematopoietic stem-cell therapy(Assistance Publique Hopitaux De Paris)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsMyelodysplastic SyndromesAnemia, Aplastic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAssistance Publique Hopitaux De Paris
China Registration ClassN/A

Develop Information

Active CompaniesAssistance Publique Hopitaux De Paris
Inactive CompaniesN/A
Active IndicationsMyelodysplastic SyndromesAnemia, Aplastic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A